Replacing benzene rings with small-ring bridged hydrocarbons can improve a drug’s physicochemical and pharmacokinetic profile. This protocol describes the synthesis of the potential meta-arene ...

As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...

Enrollment completed ahead of schedule in the first dose expansion cohortMomentum continues with first patient dosed in the second expansion ...

Enrollment completed in VIRAGE Phase 2b clinical trial of VCN-01 in metastatic pancreatic ductal adenocarcinoma (PDAC); ...

Meanwhile, a New Drug Application (NDA) for another one of Ascentage Pharma’s key drug candidates, the novel Bcl-2 selective inhibitor lisaftoclax (APG-2575), has already been accepted and granted the ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku.

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Aurinia Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress ...

New details emerge in the case against Bryan Kohberger, the man accused of fatally stabbing four University of Idaho students ...

Montgomery County police warning the community, concerned there could be more victims after a Rockville man is arrested and charged with raping a young girl. FOX 5’s Tisha Lewis joins us live ...

2006 Voluntarily at any time a Includes new drug applications, biological license applications, and efficacy supplements.